Cancel
See Linkedin
Known information
- Has been creating innovative biologics drugs and drug technologies for over 15 years in both academia and industry
- Served as VP of Biotherapeutics at Pandion Therapeutics where he played a pivotal role in growing Pandion from its earliest days in 2017 through several successful large financing rounds, an upsized IPO and the company's ultimate acquisition by Merck in 2021 for $1.85bn
- Held various positions at Pfizer where he co-invented a proprietary bispecific platform, led an antibody optimization group, and led numerous technology development, drug discovery and preclinical stage projects across a number of therapeutic areas including inflammation and immunology
- Worked at Google[x] to help launch Verily Life Sciences where he played a key role in the development of antibody-based capabilities designed to support a diagnostic nanoparticle platform
- Co-founded the MA chapter of a Pfizer Colleague Resource Group for LGBTQ+ employees and allies
- Drove Pandion’s participation in Boston Pride
- Volunteers time every week as a suicide and crisis intervention counsellor for The Trevor Project supporting LGBTQ+ youth in crisis
- Began his career in antibody technology and molecular immunology at Imperial College London on a prestigious Wellcome Trust grant, where his Ph.D focused on innovative methods for developing bi-paratopic antibodies using phage display
About Seismic Therapeutic
Seismic Therapeutic is a biotech company using machine learning to develop biologics for autoimmune diseases, with a focus on novel enzyme and antibody therapeutics.
Report inaccurate information